【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 15
1.2 List of Figures 17
2 Introduction 18
2.1 Catalyst 18
2.2 Related Reports 19
2.3 Upcoming Related Reports 20
3 Disease Overview 21
3.1 Etiology and Pathophysiology 21
3.1.1 Etiology 21
3.1.2 Pathophysiology 24
3.2 Symptoms 27
3.3 Prognosis 30
4 Epidemiology 31
4.1 Disease Background 31
4.2 Risk Factors and Comorbidities 31
4.3 Global Trends 34
4.3.1 Incidence and Geographic Distribution 34
4.3.2 Dengue Periodic and Seasonal Patterns 36
4.3.3 Dengue Serotypes 37
4.4 Forecast Methodology 38
4.4.1 Sources Used 40
4.4.2 Sources Not Used 43
4.4.3 Forecast Assumptions and Methods 43
4.5 Epidemiological Forecast for Dengue (2013-2023) 46
4.5.1 Reported Laboratory-Confirmed Dengue Cases 46
4.5.2 Sex-Specific Distribution of Reported Laboratory-Confirmed Dengue Cases 48
4.5.3 Age-Specific Distribution of Reported Laboratory-Confirmed Dengue Cases 50
4.5.4 Age-Standardized Incidence of Reported Laboratory-Confirmed Dengue 51
4.6 Discussion 52
4.6.1 Epidemiological Forecast Insight 52
4.6.2 Limitations of the Analysis 53
4.6.3 Strengths of the Analysis 54
5 Current Surveillance, Prevention, and Control Measures 55
5.1 Overview 55
5.2 Brazil 61
5.2.1 Surveillance and Diagnosis 61
5.2.2 Vector Control 61
5.2.3 Immunization Recommendations and Infrastructure 62
5.3 India 64
5.3.1 Surveillance and Diagnosis 65
5.3.2 Vector Control 65
5.3.3 Immunization Recommendations and Infrastructure 66
5.4 Mexico 68
5.4.1 Surveillance and Diagnosis 68
5.4.2 Vector Control 69
5.4.3 Immunization Recommendations and Infrastructure 70
5.5 Singapore 72
5.5.1 Surveillance and Diagnosis 72
5.5.2 Vector Control 73
5.5.3 Immunization Recommendations and Infrastructure 73
5.6 Thailand 75
5.6.1 Surveillance and Diagnosis 75
5.6.2 Vector Control 76
5.6.3 Immunization Recommendations and Infrastructure 76
6 Unmet Needs Assessment and Opportunity Analysis 79
6.1 Overview 79
6.2 Unmet Needs Analysis 81
6.2.1 Unmet Need: Safe and Efficacious Vaccines 81
6.2.2 Unmet Need: An Improved Understanding of Dengue Immunity 83
6.2.3 Unmet Need: Reliable Immunological Correlates of Protection 83
6.2.4 Unmet Need: Country-Specific Immunization Program Preparedness 84
6.2.5 Unmet Need: Upgraded Vector Control and Surveillance Infrastructures 85
6.2.6 Unmet Need: Improved Diagnostic Tools 86
6.2.7 Unmet Need: High-Quality Animal Models 87
6.3 Opportunity Analysis 88
6.3.1 Opportunity: Develop a Single-Dose Dengue Vaccine 88
6.3.2 Opportunity: Further Elucidate the Role(s) of T Cells in Dengue Immunity 88
6.3.3 Opportunity: Streamline Vaccine Development with Innovative Clinical Trial Design 89
6.3.4 Opportunity: Partner with Public Health Stakeholders to Integrate Vaccines into Multifaceted Dengue Prevention Programs 90
6.3.5 Opportunity: Establish Country-Specific Vaccine Launch Strategies 91
6.3.6 Opportunity: Leverage Diagnostics to Demonstrate Vaccine Effectiveness Post-Licensure 92
7 Research and Development Strategies 93
7.1 Overview 93
7.2 Technological Approaches to Vaccine Development 93
7.2.1 Vaccine Antigen Selection 93
7.2.2 Tetravalent Vaccine Construction 95
7.3 Partnerships, Acquisitions, and Licensing Agreements 97
7.4 Clinical Trial Design 99
7.4.1 Current Clinical Trial Design 99
7.4.2 Inclusion of Representative Patient Populations in Clinical Trials 102
7.4.3 Demonstration of Protective Efficacy 102
7.4.4 Dengue Human Infection Model 103
8 Pipeline Assessment 105
8.1 Overview 105
8.2 Live-Attenuated Vaccines in Clinical Development 110
8.2.1 CYD-TDV 110
8.2.2 DENVax 118
8.2.3 TV-003 123
8.3 Other Vaccines in Clinical Development 129
8.3.1 TDENV-PIV 129
8.3.2 DEN-80E 131
8.4 Vaccines in Preclinical Development 135
9 Pipeline Valuation Analysis 137
9.1 Clinical Benchmarking of Key Pipeline Vaccines 137
9.2 Commercial Benchmarking of Key Pipeline Vaccines 139
9.3 Competitive Assessment 141
9.4 Top-Line Five-Year Forecast 143
9.4.1 Brazil 146
9.4.2 India 147
9.4.3 Mexico 148
9.4.4 Singapore 148
9.4.5 Thailand 149
10 Appendix 150
10.1 Bibliography 150
10.2 Abbreviations 170
10.3 Methodology 174
10.4 Forecasting Methodology 174
10.4.1 Vaccinated Patients 174
10.4.2 Vaccination Coverage Rates 175
10.4.3 Vaccines Included in Each Class 175
10.4.4 Vaccine Launch Dates 175
10.4.5 General Pricing Assumptions 176
10.4.6 Individual Vaccine Assumptions 177
10.4.7 Pricing of Pipeline Vaccines 180
10.5 Physicians and Specialists Included in this Study 183
10.6 About the Authors 185
10.6.1 Analyst 185
10.6.2 Epidemiologist 185
10.6.3 Therapy Area Director 186
10.6.4 Global Head of Healthcare 186
10.7 About GlobalData 187
10.8 Disclaimer 187
【レポート販売概要】
■ タイトル:グローバルにおけるデング熱ワクチン市場:事業機会分析■ 英文:OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020
■ 発行日:2014年7月14日
■ 調査会社:GlobalData
■ 商品コード:GDHC022POA
■ 調査対象地域:グローバル
- 世界の軍用レーダ市場動向2013-2023:競合環境及び戦略的インサイトThe report provides a detailed analysis of the competitive landscape of the Military Radar market. It provides an overview of key Military Radar companies catering to the Military Radar sector, together with insights such as key alliances, strategic initiatives and a brief financial analysis.
- Bronchopulmonary Dysplasia:グローバル臨床試験レビューH1, 2013Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2013" provides data on the Bronchopulmonary Dysplasia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bronchopulmonary Dysplasia. It includes an overview of the t …
- 電子棚ラベルの世界市場:製品タイプ別(LCD、セグメント化された電子ペーパー、およびフルグラフィック電子ペーパー)、コンポーネント別(ディスプレイ、バッテリー、トランシーバー、マイクロプロセッサー、その他)、通信技術別(無線周波数、赤外線、近距離無線通信、その他) 、店舗タイプ別(ハイパーマーケット、スーパーマーケット、非食品小売店、専門店、その他)The electronic shelf label market size was valued at $624.70 million in 2018, and is projected to reach $2.16 billion by 2026, growing at a CAGR of 16.70% from 2019 to 2026. The electronic shelf label (ESL) system is used for displaying product pricing on shelves. It utilizes wireless communication networks such as radio frequency (RF) technology and infrared (IR) technology to communicate with th …
- 胃部・食道胃接合部腺癌市場:日本の治療薬市場Gastric and Gastroesophageal Junction Adenocarcinoma - Japan Drug Forecast and Market Analysis to 2024 Summary Gastric and gastroesophageal junction adenocarcinoma (G/GEJAC) represents the majority of gastric cancer cases worldwide. It is the fifth most diagnosed cancer globally, and the third most common cause of cancer death in the world. The major treatments for G/GEJAC are chemotherapy-based, …
- スポーツ医学の世界市場:インプラント、関節鏡、補綴科、オーソバイオロジクス、ブレース、疼痛緩和、温熱療法、圧迫衣料、包帯、テープThe sports medicine market comprises products and devices used by professional or non-professional athletes or sportspersons to prevent and protect themselves from injuries as well as devices that enhance performance. The sports medicine products play an important role in the rehabilitation, recovery, protection, endurance, and monitoring of athletes while playing sports. Over the years, the sport …
- 2014年戦略提言:フランスの病院内感染症検査市場This new report from Venture Planning Group contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. …
- 極低温冷凍機の世界市場2015-2019About cryogenic freezers Cryogenic freezers are technologies used in storing DNA, human tissues, blood products, stem cells, umbilical cord blood, oocytes and embryos, and other sensitive medical and biological specimens. They rely on specialized mechanical systems or liquid nitrogen to operate. These freezers minimize the level of deterioration and provide maximum viability of samples as they hav …
- 軍事シミュレーションおよびバーチャル訓練の世界市場2015-2025Summary The Global Military Simulation and Virtual Training Market 2015-2025 report, published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Key Findings - The global military simulation …
- dL-イソクエン酸ラクトンの世界市場DL-Isocitric Acid Lactone (CAS 4702-32-3) Market Research Report 2013 presents comprehensive data on dl-isocitric acid lactone markets globally and regionally (Europe, Asia, North America etc.) The DL-Isocitric Acid Lactone (CAS 4702-32-3) Market Research Report 2013 includes dl-isocitric acid lactone description, covers its application areas and related patterns. It overviews dl-isocitric acid la …
- 生分解性マルチフィルムの世界市場:TPS(熱可塑性デンプン)、AAC(脂肪族・芳香族コポリエステル)、制御分解性マスターバッチMarketsandMarkets projects the global biodegradable mulch films market size to grow from USD 35.76 Million in 2016 to USD 52.43 Million by 2021, at a CAGR of 7.95% from 2016 to 2021. The growth of the biodegradable mulch films market can be attributed to the rising demand of biodegradable mulch films in greenhouse, increased applications in agriculture, and rising environmental concerns that shift …
- 皮膚炎(Dermatitis):治療薬開発パイプライン動向(2015年上半期版)Dermatitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Dermatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of a …
- 細胞内シグナル伝達の世界市場予測(~2022年):内分泌、傍分泌The cell signaling market is expected to reach USD 3.51 billion by 2022 from USD 2.53 billion in 2017, at a CAGR of 6.8%. Factors such as increasing incidence of various chronic diseases; rising funding for cell-based research activities; introduction of innovative and advanced instruments; and growing biotech and biopharmaceutical industries are driving the global cell signaling market.The cell s …
- 先進創傷ケアの世界市場:湿潤創傷治療、創傷治療デバイス、生物学的製剤Advanced wound care – assess products, developments, and revenue prospects What does the future hold for the advanced wound care market? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there. Our new 189 page report provides 115 tables, charts, and graphs covering 12 distinct submarket segments. Discover the most lucrative are …
- 細胞単離/細胞分離の世界市場予測(~2024年)“The global cell isolation market is projected to register a CAGR of 17.2% during the forecast period.”The market size for cell isolation is expected to reach USD 13.0 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 17.2%. The growth in this market is attributed to the increasing number of patients suffering from cancer and infectious diseases, increasing government funding for cell-bas …
- IOT(モノのインターネット)リーディング企業分析:インテルThe world is moving beyond standalone devices into a new era in which everything is connected. The Internet of Things (IoT) refers to uniquely identifiable objects (things) and their virtual representations in an Internet-like structure. Stated differently, the concept involves the notion that there are many things (assets, objects, etc.) in the world that may be addressed/labeled/cataloged for va …